Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | BRIP1 |
Variant | Q561* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | BRIP1 Q561* results in a premature truncation of the Brip1 protein at amino acid 561 of 1249 (UniProt.org). Q561* does not confer resistance to interstrand crosslinking agents in a BRIP1-deficient cell line in culture (PMID: 33619228), and therefore, is predicted to lead to a loss of Brip1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
BRIP1 mutant BRIP1 inact mut BRIP1 Q561* |
Transcript | NM_032043.3 |
gDNA | chr17:g.61780953G>A |
cDNA | c.1681C>T |
Protein | p.Q561* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_047436897.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525340.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525341.4 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525335.4 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525333.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525339.4 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436894.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525334.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525341.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
NM_032043.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436903.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525337.2 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436891.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525339.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436892.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525340.4 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525336.2 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436895.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436900.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436899.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525334.2 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525333.4 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436902.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436893.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436904.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525335.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525332.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525332.4 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436896.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_011525336.3 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
XM_047436901.1 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
NM_032043.2 | chr17:g.61780953G>A | c.1681C>T | p.Q561* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|